1. Home
  2. FWACW vs YDESW Comparison

FWACW vs YDESW Comparison

Compare FWACW & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FWACW

Futurewave Acquisition Corporation Warrants

N/A

Current Price

$0.03

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo YD Bio Limited Warrants

YDESW

YD Bio Limited Warrants

HOLD

Current Price

$0.23

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWACW
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
15
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FWACW
YDESW
Price
$0.03
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
370.0K
8.0K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.20
52 Week High
$0.08
$2.85

Technical Indicators

Market Signals
Indicator
FWACW
YDESW
Relative Strength Index (RSI) N/A 41.83
Support Level N/A N/A
Resistance Level N/A $0.35
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 0.00 11.22

Price Performance

Historical Comparison
FWACW
YDESW

About FWACW Futurewave Acquisition Corporation Warrants

Futurewave Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: